MedWatch

CEO: we are talking many millions

A Danish biotech company has been granted EU funds for the continued development of a malaria vaccine. The funding could be a gateway to improving other vaccines from the company as well.

Foto: Colourbox

In collaboration with the Dutch biotech company Mucosis and University of Copenhagen, the Danish company ExpreS2ion Biotechnologies has been awarded so-called Eurostar funding from the EU.

The two biotech companies and the university will work together on the further development of a malaria vaccine for pregnant women. ExpreS2ion Biotechnologies is already developing the vaccine with funding from The Danish National Advanced Technology Foundation.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier